Josep Catllà | Ipsen Leadership
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership
  4. Josep Catllà

Josep Catllà

Back
Josep Catllà

Josep Catllà

  • Executive Vice President,
  • Chief Corporate Affairs Officer
  • Follow in LinkedIn

Josep Catllà joined Ipsen in August 2024, as Executive Vice President, Chief Corporate Affairs Officer.

Josep brings 30 years of experience in the world of communications and public affairs/government relations. He worked in the European Commission in Brussels in the early 1990s and later at the Cabinet of the President of the EU Committee of the Regions. In 1998 he went back to Spain as the Director of Communication at Forum de las Culturas Barcelona-2004, a partnership between the Spanish government and the UNESCO. In 2001 he joined Weber Shandwick where he served as CEO for Weber Shandwick Brussels – chairing its European Public Affairs Practice, and afterwards as CEO for Spain & Portugal until 2010 when he joined the pharmaceutical industry.

Prior to joining Ipsen, Josep served as SVP, Head of Corporate Affairs at Sanofi where he led the Communications, Public Affairs and Sustainability strategies after having held various leadership positions at country, region, and corporate levels during 14 years.

Josep holds a BBA by the European University and a Masters in International Relations from the Université Libre de Bruxelles.

Related stories

Imagining More for Rare Diseases: Reflections on the Path Ahead
27 February 2025 3 mins read

Imagining More for Rare Diseases: Reflections on the Path Ahead

IPN price

€103.00

 €-0.70 (-0.68%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Sustainability
  • Patients
  • Stories
  • Annual Report
  • Contact us

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue